Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
- DOI
- 10.1002/mds.25859
- Published
- 2014 May
- Container
- Movement disorders : official journal of the Movement Disorder Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/mds.25859,
title = {Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.},
author = {Ko WK and Pioli E and Li Q and McGuire S and Dufour A and Sherer TB and Bezard E and Facheris MF},
year = {2014},
journal = {Movement disorders : official journal of the Movement Disorder Society},
doi = {10.1002/mds.25859},
url = {https://doi.org/10.1002/mds.25859}
}RIS
TY - JOUR TI - Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. AU - Ko WK AU - Pioli E AU - Li Q AU - McGuire S AU - Dufour A AU - Sherer TB AU - Bezard E AU - Facheris MF PY - 2014 JO - Movement disorders : official journal of the Movement Disorder Society DO - 10.1002/mds.25859 UR - https://doi.org/10.1002/mds.25859 ER -
APA
WK, K., E, P., Q, L., S, M., A, D., TB, S., E, B., & MF, F. (2014). Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.. Movement disorders : official journal of the Movement Disorder Society. https://doi.org/10.1002/mds.25859
Source records
- pubmed · retrieved 2026-09-26T19:30:38.263Z